Kura Oncology
Patents, Design & Utilities
Last updated:
List of all Kura Oncology patents 25 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: METHODS OF TREATING SQUAMOUS CELL CARCINOMAS WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: THERAPIES FOR SQUAMOUS CELL CARCINOMAS Filling date: 26 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 6 Jan 2022 |
Grant | Utility: Methods of treating cancer patients with farnesyltransferase inhibitors Filling date: 26 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: METHODS OF TREATING CANCER PATIENTS WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 9 Dec 2021 |
Grant | Utility: Methods of treating cancer patients with farnesyltransferase inhibitors Filling date: 26 Sep 2025 Issue date: 21 Sep 2021 |
Application | Utility: SYNTHESIS OF TIPIFARNIB Filling date: 26 Sep 2025 Issue date: 12 Aug 2021 |
Grant | Utility: Methods of treating cancer with farnesyltransferase inhibitors Filling date: 26 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: BRIDGED BICYCLIC INHIBITORS OF MENIN-MLL AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 8 Apr 2021 |
Grant | Utility: Methods of treating cancer with farnesyltransferase inhibitors Filling date: 26 Sep 2025 Issue date: 20 Oct 2020 |
Grant | Utility: Substituted inhibitors of menin-MLL and methods of use Filling date: 26 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Bridged bicyclic inhibitors of menin-MLL and methods of use Filling date: 26 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING THE INTERACTION OF MENIN WITH MLL PROTEINS Filling date: 26 Sep 2025 Issue date: 28 May 2020 |
Grant | Utility: Methods and compositions for inhibiting the interaction of menin with MLL proteins Filling date: 26 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 2 Jan 2020 |
Grant | Utility: Methods of treating cancer patients with farnesyltransferase inhibitors Filling date: 26 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Methods of treating cancer with farnesyltransferase inhibitors Filling date: 26 Sep 2025 Issue date: 1 Oct 2019 |
Application | Utility: INHIBITORS OF ERK AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 26 Sep 2019 |
Showing 1 to 25 of 25 patents.